10 September 2026
Swissmedic: New guideline «Schweizerische Gute Praxis der Materiovigilance in der In-vitro-Diagnostik» (GPMV-IVD)
Swissmedic publishes the new «Schweizerische Gute Praxis der Materiovigilance in der In-vitro-Diagnostik» (GPMV-IVD). This guideline is intended to support professionals using in vitro diagnostic medical devices (IVDs) for medical purposes, as well as persons responsible for the implementation of medical device vigilance in the field of in vitro diagnostics.
For more information, see here.
More News
-
-
Swissmedic: New strategic Approach to minimizing Animal Testing in the Development of Medicinal Products
-
European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes
-
Swissmedic: The new Pharmacopoea Helvetica 13
-
FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient
-
Decision C-6534/2024 of 13 October 2026
-
Swissmedic: Haemovigilance Annual Report 2025
-
Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues
-
European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent
-
European Medicines Agency: Highlights of the September 2026 Management Board meeting